A Midtown-based diagnostics company raised capital in a deal to advance its novel approach to screening for the risk factors ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

Researchers at Case Western Reserve University (CWRU) and University Hospitals (UH) will use state-of-the-art medical ...

Medically reviewed by Qin Rao, MD Barrett's esophagus occurs when the lining of the esophagus, the tube that runs from the ...

New indication for Tevimbra in combination with platinum-containing chemotherapy as a first-line treatment addresses an unmet ...

BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1 ...

Study finds Mediterranean diet reduces cancer risks linked to obesity, especially for colorectal, liver and kidney cancers, ...

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

Osamu Nishimura, a prominent Japanese wrestler, has died at 53 after battling esophageal cancer. Despite his late-stage ...